These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Onabotulinumtoxin A is under clinical development by AbbVie and currently in Phase III for Unspecified Musculoskeletal Disorders.

AKP-11 is under clinical development by Akaal Pharma and currently in Phase I for Autoimmune Disorders. According to GlobalData, Phase I drugs for Autoimmune Disorders have a 73% phase transition ...

Pain is one of the most debilitating symptoms that presents with neuropathy. Neuropathic pain syndrome is a challenge to treat and, even with appropriate evidence-based treatment, only a 40% ...

Neuropathic Pain Drugs Found to Increase Risk of Hip Fracture in Older Adults Nov. 13, 2024 — A new study by medicine safety experts found the use of gabapentinoids -- medicines widely used to ...

Aging Health. 2011;7(6):813-828. Common opioid side effects reported in the literature include urinary retention, pruritus, nausea and vomiting, CNS effects and respiratory effects. The incidence ...

Neuropathic Pain Drugs Found to Increase Risk of Hip Fracture in Older Adults Nov. 13, 2024 — A new study by medicine safety experts found the use of gabapentinoids -- medicines widely used to ...